Blastocystis hominis (2)

Embed Size (px)

Citation preview

  • 8/4/2019 Blastocystis hominis (2)

    1/25

    Blastocystis

    hominis

  • 8/4/2019 Blastocystis hominis (2)

    2/25

  • 8/4/2019 Blastocystis hominis (2)

    3/25

    HistoryA species of parasitic protozoa found inthe intestines of humans and otherprimates.It was classified as a yeast in 1912. Over

    the years, questions arose about thisdesignation. In 1967, many physiologicaland morphological B. hominis characteristics were reported that fit aprotozoan classification.

  • 8/4/2019 Blastocystis hominis (2)

    4/25

    It is now recognized as aprotozoan parasite of humanscausing intestinal disease withpotentially disabling symptoms.

  • 8/4/2019 Blastocystis hominis (2)

    5/25

    IntroductionDisease caused by this parasite:BlastocystosisBlastocystis Hominis is a protozoan intestinalparasite belonging to the Blastocystis genusof Stramenopiles.It has a widespread geographic distributionand is found in countries of all income levelsacross the world.Its status as a true pathogen is controversial- while it has been found in patients withgastrointestinal symptoms, it is not proven tobe the cause, and many carriers areasymptomatic.

  • 8/4/2019 Blastocystis hominis (2)

    6/25

    VacuolatedUnicellular, it is 5-30 micra indiameter, with the usual range

    being 8-10 micra.spherical, oval, or ellipsoidal,with usually one, butsometimes 2-4 nuclei locatedin the rim of the cytoplasm.

    Morphology

  • 8/4/2019 Blastocystis hominis (2)

    7/25

  • 8/4/2019 Blastocystis hominis (2)

    8/25

    Morphology

    Granular form is morphologicallysimilar to vacuolar form except that

    distinct granules are observed in thecentral vacuole or cytoplasm.These granules appear in 3 differentforms: Metabolic, Lipid and Reproductivegranules.These granules may be an indication thatthe cell is dying.

  • 8/4/2019 Blastocystis hominis (2)

    9/25

    Morphology

    Multivacuolar and avacuolar forms: These contain many smaller vacuoles or novacuoles within a smaller cell of between 5 and8 micrometers in diameter.1 nucleus tends to be present, with a maximumof two.

  • 8/4/2019 Blastocystis hominis (2)

    10/25

    Morphology

    Ameboid form:This is a very rare form withirregularly shaped cells

    from 2.6 to 7.8 micrometersin diameter.Pseudopodia are oftenattached. A large centralvacuole may or may not bepresent.

  • 8/4/2019 Blastocystis hominis (2)

    11/25

    Morphology

    Amoeboid formnon-motile and strongly adhesive.

    A study has reported that amoeboid formsare produced only in cultures taken fromsymptomatic individuals. The studysuggested using amoeboid forms for

    diagnosing symptomatic infection.Symptoms is due to strongly adhesiveamoeboid forms in the hosts intestinalwall.

  • 8/4/2019 Blastocystis hominis (2)

    12/25

    Morphology

    Cyst form:A hard, resistive formbetween 3 and 10micrometers indiameter.A thick wallencapsulates the

    structure whichincludes manyvacuoles and 1 or 2nuclei.

  • 8/4/2019 Blastocystis hominis (2)

    13/25

    Morphology

    Cyst form Most resistant form of the parasite, it

    is able to survive harsh conditionsbecause of its thick multilayered cystwall.

  • 8/4/2019 Blastocystis hominis (2)

    14/25

    Form Size(micra) SourceCentralvacuole

    Surfacecoat

    Number ofnuclei

    Otherremarks

    Vacuolar 2 - >200 Culture,feces

    Present Present(thin) or

    absent

    1-4 Centralvacuole

    occupiesmost of cellvolume

    Granular 5-80 Culture,feces

    Present Present(thin) orabsent

    1-4 Granules incentralvacuole;

    morphologysimilar tovacuolarform

    Multivacuolar 5-8 Feces,culture

    Absent Present(thick)

    1 or 2 Multiplesmall

    vacuoles(may be toosmall toresolve bylightmicroscopy)

  • 8/4/2019 Blastocystis hominis (2)

    15/25

    Avacuolar ~5 Intestine,feces

    Absent Absent 1 or 2 Rarelyreported

    Amoeboid 2.6-7.8 Feces,culture Absent Absent 1 or 2 Rarelyreported;conflictinginformation onmorphology

    Cyst 3-10 Feces,culture

    Absent Presentor absent

    1-2 Cyst wallpresent(beneathsurfacecoat)

  • 8/4/2019 Blastocystis hominis (2)

    16/25

    Life Cycle

  • 8/4/2019 Blastocystis hominis (2)

    17/25

    This is a proposed life cycle for B.

    hominis 1) The cyst form is found in human stools, which

    varies in size from 6 to 40 m .2) The thick-walled cyst present in the stools is

    responsible for external transmission, possibly bythe fecal-oral route through ingestion ofcontaminated water or food .

    3) The cysts infect epithelial cells of the digestive tractand multiply asexually.

    4) Vacuolar forms of the parasite give origin to multivacuolar and amoeboid forms.

    5) The multi-vacuolar develops into a pre-cyst thatgives origin to a thin-walled cyst , responsible forautoinfection.

    6) The amoeboid form gives origin to a pre-cyst ,

    which develops into thick-walled cyst byschizogony . The thick-walled cyst is excreted in

  • 8/4/2019 Blastocystis hominis (2)

    18/25

    LIFE CYCLE

    Infective Stage: Thick-walledCystDiagnostic Stage: all forms,cyst and vacuolated forms are

    most common

  • 8/4/2019 Blastocystis hominis (2)

    19/25

    Clinical Presentation in Humans:

    Blastocystosis, as well as its diagnosis, iscontroversial because it has not been proven thatassociated symptoms come from Blastocystishominis itself. It is argued that many people

    found to harbor blastocystis might have othersources of their symptoms.

    Watery diarrhea

    Abdominal pain / crampsPerianal pruritis (itch)Excessive flatulence

  • 8/4/2019 Blastocystis hominis (2)

    20/25

    Transmission

    Transmission is thought to be throughthe fecal-oral route, much like that of

    other better-known GI protozoa,although there is no experimentalconfirmation. It is probable that the

    infectious form is the cyst form.

  • 8/4/2019 Blastocystis hominis (2)

    21/25

    Diagnostic Tests:B. hominis is usually diagnosed by microscopicexamination of fecal material stained withiodine or trichrome.Permanent stained smear is preferred becausefecal debris might be mistaken for theorganism in wet preparations.ELISA and fluorescent-antibody tests

    Most prominent form in the feces is thevacuolar form, all forms have been found.

  • 8/4/2019 Blastocystis hominis (2)

    22/25

    Management and Therapy:Anti-protozoan drugs have been usedUsually treated with Metronidazole , which hasbeen effective, but shows signs of resistance

    by B. hominis or limited effectiveness in others.Also used the drug combinationTrimethoprim/Sulfamethoxazole (TMP/SMX)with similar effects.More recently, Nitazoxanide has been with

    much more positive effects,

  • 8/4/2019 Blastocystis hominis (2)

    23/25

    Epidemiology

    This disease is not well-tracked, but appears tooccur worldwide. Case reports indicate thatwhile nearly worldwide in distribution, it is more

    common in less developed nations and mayprefer tropical and sub-tropical climates.Proximity to pets and farm animals alsoappears to be linked with increased infectionrates.

    2-3 times higher in day care centers and 4-6times higher in primary schools than in the

    general population.

  • 8/4/2019 Blastocystis hominis (2)

    24/25

    Public Health and PreventionStrategies

    Following ways to prevent infection with B.hominis:Wash hands with soap and water afterusing the toilet and before handling food.Avoid water or food that may becontaminated.Wash and peel all raw vegetables andfruits before eating.

  • 8/4/2019 Blastocystis hominis (2)

    25/25

    REFERENCES:

    Centers for Disease Control and Preventionhttp://www.stanford.edu/group/parasites/ParaSites2010/Delamon_Alfredo_Rego/paraSITEfinalweb.htm